Acute Myeloid Leukemia With MLL Rearrangement and CD4+/CD56+ Expression can be Misdiagnosed as Blastic Plasmacytoid Dendritic Cell Neoplasm: Two Case Reports

نویسندگان

  • Ju-Mee Lee
  • In-Suk Kim
  • Jeong Nyeo Lee
  • Sang Hyuk Park
  • Hyung-Hoi Kim
  • Chulhun L. Chang
  • Eun Yup Lee
  • Hye Ran Kim
  • Seung Hwan Oh
  • Sae Am Song
چکیده

Ju-Mee Lee, M.D., In-Suk Kim, M.D., Jeong Nyeo Lee, M.D., Sang Hyuk Park, M.D. Hyung-Hoi Kim, M.D., Chulhun L. Chang, M.D., Eun Yup Lee, M.D., Hye Ran Kim, M.D., Seung Hwan Oh, M.D., and Sae Am Song, M.D. Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Yangsan; Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan; Department of Laboratory Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan; Department of Laboratory Medicine, Pusan National University School of Medicine, Busan; Department of Laboratory Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Blastic Plasmacytoid Dendritic Cell Neoplasm; A Report of Three Cases

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematodermic myeloid malignancy that is known to be derived from plasmacytoid dendritic cells which are characterized by expression of CD4, CD56, and more specific markers such as CD123. Here, the authors present three cases of BPDCN diagnosed in the past two years and address different available diagnostic modalities such as morpho...

متن کامل

Flow cytometry to identify bone-marrow relapse in blastic plasmacytoid dendritic cell neoplasm: a case report

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare acute leukemia subtype characterized by clonal expansion of dendritic-lineage cells.1 These cells are identified immunophenotypically by weak CD45 expression and coexpression of the CD4 and CD56 antigens in the absence of other lineage-specific markers.2,3 Previously known as blastic natural killer (NK)-cell lymphoma or CD4+/CD56+ h...

متن کامل

Cutaneous lesions from a blastic plasmacytoid dendritic cell neoplasm: a case report and literature review

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematological malignancy that is derived from the precursors of plasmacytoid dendritic cells. Although BPDCN typically manifests in the skin, it can also evolve into a leukemic form or be complicated by acute myeloid leukemia, and some cases involve preceding myelodysplastic syndrome. We report the case of a 73...

متن کامل

Reduced Intensity Allogeneic Stem Cell Transplant for Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Blastic plasmacytoid dendritic cell neoplasm is a rare, aggressive tumor characterized by skin and/or marrow infiltration by CD4(+) CD56(+) cells. Historically, the tumor was variably thought to arise from either monocytes, T cells or NK cells giving rise to terms such as CD4(+)/CD56(+) acute monoblastic leukemia, primary cutaneous CD4(+)/CD56(+) hematodermic tumor and blastic NK-cell lymphoma....

متن کامل

Blastic Plasmacytoid Dendritic Cell Neoplasm --a Rapidly Evolving Entity. Case Report.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN), CD4+/CD56+hematodermic neoplasm was formally known as blastic NK-cell lymphoma. It is in fact a form of acute myeloid leukemia notable for highly aggressive behavior with cutaneous, lymph node and bone marrow involvement. This entity is derived from plasmocytoid dendritic cells and has a predilection for extranodal sites, especially the skin...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 36  شماره 

صفحات  -

تاریخ انتشار 2016